CORD-19:16a812de72963ceda960a168236e8dbe91832d45 / 14736-14922 JSONTXT

Annnotations TAB JSON ListView MergeView

    CORD-19_Custom_license_subset

    {"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T79","span":{"begin":0,"end":186},"obj":"Sentence"}],"text":"Remyelination as Neuroprotection associated with chronic demyelination induced by cuprizone treatment, with axon diameter being reduced to 60% of normal after 16 weeks of demyelination ."}

    CORD-19-Sentences

    {"project":"CORD-19-Sentences","denotations":[{"id":"TextSentencer_T79","span":{"begin":0,"end":186},"obj":"Sentence"},{"id":"TextSentencer_T79","span":{"begin":0,"end":186},"obj":"Sentence"},{"id":"T49121","span":{"begin":0,"end":186},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Remyelination as Neuroprotection associated with chronic demyelination induced by cuprizone treatment, with axon diameter being reduced to 60% of normal after 16 weeks of demyelination ."}

    Epistemic_Statements

    {"project":"Epistemic_Statements","denotations":[{"id":"T38","span":{"begin":0,"end":186},"obj":"Epistemic_statement"}],"text":"Remyelination as Neuroprotection associated with chronic demyelination induced by cuprizone treatment, with axon diameter being reduced to 60% of normal after 16 weeks of demyelination ."}

    CORD-19-PD-HP

    {"project":"CORD-19-PD-HP","denotations":[{"id":"T35","span":{"begin":57,"end":70},"obj":"Phenotype"},{"id":"T36","span":{"begin":171,"end":184},"obj":"Phenotype"}],"attributes":[{"id":"A35","pred":"hp_id","subj":"T35","obj":"http://purl.obolibrary.org/obo/HP_0011096"},{"id":"A36","pred":"hp_id","subj":"T36","obj":"http://purl.obolibrary.org/obo/HP_0011096"}],"text":"Remyelination as Neuroprotection associated with chronic demyelination induced by cuprizone treatment, with axon diameter being reduced to 60% of normal after 16 weeks of demyelination ."}